Trisodium;2-[[2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexyl)oxy-oxidophosphoryl]oxypropyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+);hydrate (BioDeep_00000859043)

   


代谢物信息卡片


Trisodium;2-[[2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexyl)oxy-oxidophosphoryl]oxypropyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+);hydrate

化学式: C33H40GdN3Na3O15P (976.113115)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1CC(CCC1OP(=O)([O-])OCC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.O.[Na+].[Na+].[Na+].[Gd+3]
InChI: +3



数据库引用编号

3 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Begoña Lavin, Andrea Protti, Silvia Lorrio, Xuebin Dong, Alkystis Phinikaridou, René M Botnar, Ajay Shah. MRI with gadofosveset: A potential marker for permeability in myocardial infarction. Atherosclerosis. 2018 08; 275(?):400-408. doi: 10.1016/j.atherosclerosis.2018.04.024. [PMID: 29735362]
  • Tameshwar Ganesh, Marvin Estrada, Herman Yeger, James Duffin, Hai-Ling Margaret Cheng. A non-invasive magnetic resonance imaging approach for assessment of real-time microcirculation dynamics. Scientific reports. 2017 08; 7(1):7468. doi: 10.1038/s41598-017-06983-6. [PMID: 28784990]
  • Gregory J Wilson, Charles S Springer, Sarah Bastawrous, Jeffrey H Maki. Human whole blood 1 H2 O transverse relaxation with gadolinium-based contrast reagents: Magnetic susceptibility and transmembrane water exchange. Magnetic resonance in medicine. 2017 05; 77(5):2015-2027. doi: 10.1002/mrm.26284. [PMID: 27297589]
  • H M C Cheung, C Law, M Shoichet, P J Karanicolas, N Coburn, L Milot. Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium, an Intravascular (Blood-Pool) Contrast Agent: A Pictorial Essay. Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes. 2016 Aug; 67(3):242-9. doi: 10.1016/j.carj.2015.09.016. [PMID: 27318891]
  • Baris Turkbey, Robert F Hoyt, Harsh K Agarwal, Marcelino Bernardo, Sandeep Sankineni, Linda Johnson, Kinzya B Grant, Soroush Rais-Bahrami, Hisataka Kobayashi, Bradford J Wood, Peter A Pinto, Gary L Griffiths, Peter L Choyke. Magnetic resonance sentinel lymph node imaging of the prostate with gadofosveset trisodium-albumin: preliminary results in a canine model. Academic radiology. 2015 May; 22(5):646-52. doi: 10.1016/j.acra.2014.12.021. [PMID: 25683498]
  • Wilson B Chwang, Rajan Jain, Hassan Bagher-Ebadian, Siamak P Nejad-Davarani, A S M Iskander, Ashley VanSlooten, Lonni Schultz, Ali S Arbab, James R Ewing. Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection. Journal of magnetic resonance imaging : JMRI. 2014 Nov; 40(5):1223-9. doi: 10.1002/jmri.24469. [PMID: 24421265]
  • Stefan Goetschi, Johannes M Froehlich, Natalie C Chuck, Raffaele Curcio, Val M Runge, Gustav Andreisek, Daniel Nanz, Andreas Boss. The protein and contrast agent-specific influence of pathological plasma-protein concentration levels on contrast-enhanced magnetic resonance imaging. Investigative radiology. 2014 Sep; 49(9):608-19. doi: 10.1097/rli.0000000000000061. [PMID: 24710201]
  • Takahito Nakajima, Baris Turkbey, Kohei Sano, Kazuhide Sato, Marcelino Bernardo, Robert F Hoyt, Peter L Choyke, Hisataka Kobayashi. MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates. Journal of magnetic resonance imaging : JMRI. 2014 Sep; 40(3):691-7. doi: 10.1002/jmri.24395. [PMID: 24123370]
  • Mustafa R Bashir, Rekha Mody, Amy Neville, Ramin Javan, Danielle Seaman, Charles Y Kim, Rajan T Gupta, Tracy A Jaffe. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases. Journal of magnetic resonance imaging : JMRI. 2014 Jul; 40(1):113-8. doi: 10.1002/jmri.24330. [PMID: 24130008]
  • E Fabryova, D Jirak, P Girman, K Zacharovova, A Galisova, F Saudek, J Kriz. Effect of mesenchymal stem cells on the vascularization of the artificial site for islet transplantation in rats. Transplantation proceedings. 2014 Jul; 46(6):1963-6. doi: 10.1016/j.transproceed.2014.05.074. [PMID: 25131083]
  • O C Richardson, M L J Scott, S F Tanner, J C Waterton, D L Buckley. Overcoming the low relaxivity of gadofosveset at high field with spin locking. Magnetic resonance in medicine. 2012 Oct; 68(4):1234-8. doi: 10.1002/mrm.23316. [PMID: 22161901]
  • Alkystis Phinikaridou, Marcelo E Andia, Andrea Protti, Andreas Indermuehle, Ajay Shah, Alberto Smith, Alice Warley, René M Botnar. Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent. Circulation. 2012 Aug; 126(6):707-19. doi: 10.1161/circulationaha.112.092098. [PMID: 22753191]
  • Céline Henoumont, Sophie Laurent, Robert N Muller, Luce Vander Elst. Effect of nonenzymatic glycosylation on the magnetic resonance imaging (MRI) contrast agent binding to human serum albumin. Journal of medicinal chemistry. 2012 Apr; 55(8):4015-9. doi: 10.1021/jm3000246. [PMID: 22420713]
  • J Kriz, D Jirak, T Koblas, G Vilk, P Girman, M Hajek, F Saudek. Dynamic contrast-enhanced magnetic resonance imaging as a tool to monitor the blood supply to an artificial cavity used as a site for islet transplantation in rats. Transplantation proceedings. 2011 Nov; 43(9):3226-30. doi: 10.1016/j.transproceed.2011.09.012. [PMID: 22099763]
  • Stefano Tartari, Roberto Rizzati, Riccardo Righi, Anna Deledda, Katia Capello, Riccardo Soverini, Giorgio Benea. High-resolution MRI of carotid plaque with a neurovascular coil and contrast-enhanced MR angiography: one-stop shopping for the comprehensive assessment of carotid atherosclerosis. AJR. American journal of roentgenology. 2011 May; 196(5):1164-71. doi: 10.2214/ajr.10.4751. [PMID: 21512087]
  • Mark A Perazella, Robert F Reilly. Imaging patients with kidney disease: how do we approach contrast-related toxicity?. The American journal of the medical sciences. 2011 Mar; 341(3):215-21. doi: 10.1097/maj.0b013e3181f016e6. [PMID: 21139495]
  • Gero Wieners, Frank Meyer, Zuhir Halloul, Nils Peters, Ricarda Rühl, Oliver Dudeck, Jörg Tautenhahn, Jens Ricke, Maciej Pech. Detection of type II endoleak after endovascular aortic repair: comparison between magnetic resonance angiography and blood-pool contrast agent and dual-phase computed tomography angiography. Cardiovascular and interventional radiology. 2010 Dec; 33(6):1135-42. doi: 10.1007/s00270-010-9984-x. [PMID: 20924762]
  • J Kuhlemann, D Blondin, D Grotemeyer, P Zgoura, D Reichelt, W Heinen, A Scherer, R S Lanzman. Gadofosveset-enhanced MR imaging for the preoperative evaluation of potential living kidney donors: correlation with intraoperative findings. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2010 Nov; 182(11):1001-9. doi: 10.1055/s-0029-1245685. [PMID: 20922646]
  • Constantina Chrysochou, Albert Power, Aladdin E Shurrab, Sayed Husain, Steven Moser, James Lay, Alan D Salama, Philip A Kalra. Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. Clinical journal of the American Society of Nephrology : CJASN. 2010 Mar; 5(3):484-9. doi: 10.2215/cjn.06580909. [PMID: 20093350]
  • Peter Caravan. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Accounts of chemical research. 2009 Jul; 42(7):851-62. doi: 10.1021/ar800220p. [PMID: 19222207]
  • Jamu K Alford, Brian K Rutt, Timothy J Scholl, William B Handler, Blaine A Chronik. Delta relaxation enhanced MR: improving activation-specificity of molecular probes through R1 dispersion imaging. Magnetic resonance in medicine. 2009 Apr; 61(4):796-802. doi: 10.1002/mrm.21933. [PMID: 19189292]
  • Lutz Lüdemann, Benno Nafz, Franz Elsner, Christian Grosse-Siestrup, Michael Meissler, Nicola Kaufels, Hagen Rehbein, Pontus B Persson, Henrik J Michaely, Philipp Lengsfeld, Matthias Voth, Matthias Gutberlet. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent. Investigative radiology. 2009 Mar; 44(3):125-34. doi: 10.1097/rli.0b013e318193598c. [PMID: 19151609]
  • N P Blockley, L Jiang, A G Gardener, C N Ludman, S T Francis, P A Gowland. Field strength dependence of R1 and R2* relaxivities of human whole blood to ProHance, Vasovist, and deoxyhemoglobin. Magnetic resonance in medicine. 2008 Dec; 60(6):1313-20. doi: 10.1002/mrm.21792. [PMID: 19030165]
  • Kai Nassenstein, Kai-Uwe Waltering, Sebastian Kelle, Thomas Schlosser, Frank Breuckmann, Stefan Maderwald, Peter Hunold, Eike Nagel, Jörg Barkhausen. Magnetic resonance coronary angiography with Vasovist: in-vivo T1 estimation to improve image quality of navigator and breath-hold techniques. European radiology. 2008 Jan; 18(1):103-9. doi: 10.1007/s00330-007-0720-0. [PMID: 17701041]
  • Jens Bremerich, Deniz Bilecen, Peter Reimer. MR angiography with blood pool contrast agents. European radiology. 2007 Dec; 17(12):3017-24. doi: 10.1007/s00330-007-0712-0. [PMID: 17639407]
  • Peter Caravan, Giacomo Parigi, Jaclyn M Chasse, Normand J Cloutier, Jeffrey J Ellison, Randall B Lauffer, Claudio Luchinat, Sarah A McDermid, Marga Spiller, Thomas J McMurry. Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. Inorganic chemistry. 2007 Aug; 46(16):6632-9. doi: 10.1021/ic700686k. [PMID: 17625839]
  • Zoltan Tyeklar, Stephen U Dunham, Katarina Midelfort, Daniel M Scott, Hirano Sajiki, Karen Ong, Randall B Lauffer, Peter Caravan, Thomas J McMurry. Structural, kinetic, and thermodynamic characterization of the interconverting isomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. Inorganic chemistry. 2007 Aug; 46(16):6621-31. doi: 10.1021/ic7006843. [PMID: 17625838]
  • Martin Rohrer, Liesbeth Geerts-Ossevoort, Gerhard Laub. Technical requirements, biophysical considerations and protocol optimization with magnetic resonance angiography using blood-pool agents. European radiology. 2007 Mar; 17 Suppl 2(?):B7-12. doi: NULL. [PMID: 17650554]
  • Kohkan Shamsi, E Kent Yucel, Paul Chamberlin. A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase III clinical trials data. Investigative radiology. 2006 Nov; 41(11):822-30. doi: 10.1097/01.rli.0000242836.25299.8f. [PMID: 17035873]
  • Thomas Steger-Hartmann, Philip B Graham, Simone Müller, Hermann Schweinfurth. Preclinical safety assessment of Vasovist (Gadofosveset trisodium), a new magnetic resonance imaging contrast agent for angiography. Investigative radiology. 2006 May; 41(5):449-59. doi: 10.1097/01.rli.0000208223.34203.49. [PMID: 16625108]
  • Harriet B Eldredge, Marga Spiller, Jaclyn M Chasse, Matthew T Greenwood, Peter Caravan. Species dependence on plasma protein binding and relaxivity of the gadolinium-based MRI contrast agent MS-325. Investigative radiology. 2006 Mar; 41(3):229-43. doi: 10.1097/01.rli.0000199293.86956.48. [PMID: 16481905]
  • Mike Hartmann, Andrea J Wiethoff, Hans-Rainer Hentrich, Martin Rohrer. Initial imaging recommendations for Vasovist angiography. European radiology. 2006 Feb; 16 Suppl 2(?):B15-23. doi: 10.1007/s10406-006-0163-8. [PMID: 16802439]
  • Sheridan Henness, Gillian M Keating. Gadofosveset. Drugs. 2006; 66(6):851-7. doi: 10.2165/00003495-200666060-00008. [PMID: 16706555]
  • Marc Port, Claire Corot, Xavier Violas, Philippe Robert, Isabelle Raynal, Georgia Gagneur. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity. Investigative radiology. 2005 Sep; 40(9):565-73. doi: 10.1097/01.rli.0000175388.98721.9b. [PMID: 16118549]
  • Yantian Zhang, Peter L Choyke, Huiyan Lu, Hideko Takahashi, Roslyn B Mannon, Xiaojie Zhang, Hani Marcos, King C P Li, Jeffrey B Kopp. Detection and localization of proteinuria by dynamic contrast-enhanced magnetic resonance imaging using MS325. Journal of the American Society of Nephrology : JASN. 2005 Jun; 16(6):1752-7. doi: 10.1681/asn.2004110981. [PMID: 15872075]
  • NULL. Molecule of the month. Gadofosveset sodium. Drug news & perspectives. 2004 Oct; 17(8):538. doi: NULL. [PMID: 15605113]
  • Xiangzhi Zhou, Peter Caravan, R B Clarkson, Per-Olof Westlund. On the philosophy of optimizing contrast agents. An analysis of 1H NMRD profiles and ESR lineshapes of the Gd(III)complex MS-325+HSA. Journal of magnetic resonance (San Diego, Calif. : 1997). 2004 Mar; 167(1):147-60. doi: 10.1016/j.jmr.2003.12.006. [PMID: 14987609]
  • NULL. Gadofosveset: MS 325, MS 32520, Vasovist, ZK 236018. Drugs in R&D. 2004; 5(6):339-42. doi: 10.2165/00126839-200405060-00005. [PMID: 15563237]
  • Peter Caravan, Normand J Cloutier, Matthew T Greenfield, Sarah A McDermid, Stephen U Dunham, Jeff W M Bulte, John C Amedio, Richard J Looby, Ronald M Supkowski, William DeW Horrocks, Thomas J McMurry, Randall B Lauffer. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. Journal of the American Chemical Society. 2002 Mar; 124(12):3152-62. doi: 10.1021/ja017168k. [PMID: 11902904]
  • K Turetschek, E Floyd, T Helbich, T P Roberts, D M Shames, M F Wendland, W O Carter, R C Brasch. MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology. Journal of magnetic resonance imaging : JMRI. 2001 Sep; 14(3):237-42. doi: 10.1002/jmri.1179. [PMID: 11536400]
  • P V Prasad, J Cannillo, D R Chavez, E S Pinchasin, R P Dolan, R Walovitch, R R Edelman. First-pass renal perfusion imaging using MS-325, an albumin-targeted MRI contrast agent. Investigative radiology. 1999 Sep; 34(9):566-71. doi: 10.1097/00004424-199909000-00003. [PMID: 10485071]
  • R B Lauffer, D J Parmelee, S U Dunham, H S Ouellet, R P Dolan, S Witte, T J McMurry, R C Walovitch. MS-325: albumin-targeted contrast agent for MR angiography. Radiology. 1998 May; 207(2):529-38. doi: 10.1148/radiology.207.2.9577506. [PMID: 9577506]
  • D J Parmelee, R C Walovitch, H S Ouellet, R B Lauffer. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Investigative radiology. 1997 Dec; 32(12):741-7. doi: 10.1097/00004424-199712000-00004. [PMID: 9406014]